[HTML][HTML] 新生儿急性呼吸窘迫综合征研究进展
迟明 - Chinese Journal of Contemporary Pediatrics, 2018 - ncbi.nlm.nih.gov
… It is an acute pulmonary inflammatory disease caused by the lack of pulmonary surfactant
(PS) related to various pathological factors. It is difficult to distinguish neonatal ARDS from …
(PS) related to various pathological factors. It is difficult to distinguish neonatal ARDS from …
[PDF][PDF] 外源性肺表面活性物质治疗新生儿呼吸窘迫综合征临床方法学研究
钱文亚， 谢晓恬 - 世界临床药物, 2020 - jwph.com.cn
… pulmonary surfactant. This paper summarized the domestic and foreign literatures in the past
… range of exogenous pulmonary surfactant in the treatment of NRDS for clinical reference. …
… range of exogenous pulmonary surfactant in the treatment of NRDS for clinical reference. …
[HTML][HTML] 肺动脉血流指数及肺表面活性蛋白水平对重度子痫前期合并妊娠期糖尿病孕妇围生儿肺成熟度的临床应用价值
王艳， 郭凤军， 查文慧， 刘畅… - 中华妇幼临床医学 …, 2021 - zhfylcyxzz.cma-cmc.com.cn
… To investigate clinical values of pulsatility indexes (PI) and resistance indexes (RI) of fetal
pulmonary artery, and pulmonary surfactant protein (SP)-A, SP-B levels in neonatal umbilical …
pulmonary artery, and pulmonary surfactant protein (SP)-A, SP-B levels in neonatal umbilical …
[PDF][PDF] kk 燃mixed micelles as nanocarriers for drugs and imaging probes, evaluating their ongoing status (preclinical or clinical
MA Moretton, DA Chiappetta - European Journal of Pharmaceutics …, 2017 - researchgate.net
… The cloud point (CP) is the temperature at which a non-ionic surfactant solution presents a
… by a decrease of the surfactant solubility in water, as the surfactant polar head and water …
… by a decrease of the surfactant solubility in water, as the surfactant polar head and water …
Uncovering the action mechanism of Shenqi Tiaoshen formula (参芪调肾方) in the treatment of chronic obstructive pulmonary disease through network pharmacology …
Y Qinjun, YIN Dandan, W Hui… - Journal of …, 2024 - search.ebscohost.com
OBJECTIVE: To reveal the potential underlying mechanism of the Shenqi Tiaoshen formula (参
芪调肾方, SQTS) in the treatment of chronic obstructive pulmonary disease (COPD) by …
芪调肾方, SQTS) in the treatment of chronic obstructive pulmonary disease (COPD) by …
[HTML][HTML] 肺成体干细胞体外培养模型的研究进展
李童， 杨劲树， 杨卫军 - 生物工程学报, 2022 - cjb.ijournals.cn
… 的功能 [31] ;第二类为Ⅱ型肺泡细胞,维持肺泡稳态和损伤修复 [32] ,AT2 cell特有的细胞器是板
层小体,能够产生表面活性蛋白(pulmonary surfactant proteins),降低表面张力,防止肺泡塌陷 [33] . …
层小体,能够产生表面活性蛋白(pulmonary surfactant proteins),降低表面张力,防止肺泡塌陷 [33] . …
维生素A 生物合成的研究进展
王欣慧， 王颖， 姚明东， 肖文海 - 化工学报, 2022 - hgxb.cip.com.cn
… Enhancement of retinal production by supplementing the surfactant Span 80 using metabolically
engineered Escherichia coli [J]. Journal of Bioscience and Bioengineering, 2012, 113(4)…
engineered Escherichia coli [J]. Journal of Bioscience and Bioengineering, 2012, 113(4)…
金属氧化物纳米颗粒生物毒性效应及毒性机理研究进展
Y Wang, L Ding, C Yao, C Li, X Xing, Y Huang… - Science China …, 2017 - Springer
纳米材料由于其独特的性质已经被广泛应用于很多领域, 但随着纳米材料的大规模制备和广泛
应用, 它对环境以及人类的潜在危害越来越引起人们的重视. 金属氧化物纳米颗粒(MONPs)作为一…
应用, 它对环境以及人类的潜在危害越来越引起人们的重视. 金属氧化物纳米颗粒(MONPs)作为一…
[HTML][HTML] CONSORT 2010 说明与详述: 报告平行对照随机临床试验指南的更新
Overwhelming evidence shows the quality of reporting of randomised controlled trials (RCTs)
is not optimal. Without transparent reporting, readers cannot judge the reliability and …
is not optimal. Without transparent reporting, readers cannot judge the reliability and …
从电气和电子废物中浸出金属元素的微生物方法
JA SNEHA, G KALAICHELVAN - 资源与生态学报, 2023 - jorae.cn
… The organic compounds and surfactants used while solvent extraction also could inhibit the
bioleaching bacteria. This can be caused by the lowering of surface tension and decrease of …
bioleaching bacteria. This can be caused by the lowering of surface tension and decrease of …